Candida glabrata has emerged as one of the most common causes of candidosis
. In order to identify factors that are necessary for viability and pathoge
nicity of this fungal pathogen, we analysed the role of the KEX2 gene, whic
h codes for a regulatory endoproteinase that is known to process certain vi
rulence factors in Candida albicans. The KEX2 gene from C. glabrata was clo
ned and found to have 51% and 62% identity and high structural similarities
to the homologous counterparts in C. albicans and Saccharomyces cerevisiae
. KEX2 was expressed at all time points investigated during growth in compl
ex medium. In order to investigate the role of this putative regulatory pro
teinase, Kex2-deficient mutants were produced. In addition to known kex2 ph
enotypes, such as pH and calcium hypersensitivity, the mutants grew in cell
ular aggregates and were found to be hypersensitive to several antifungal d
rugs that target the cell membrane, including azoles, amorolfine and amphot
ericin B. Ultrastructural investigation after exposure to low doses of itra
conazole showed azole-specific alterations such as enlarged vacuoles and pr
oliferation of the cytoplasmatic membrane in the kex2 mutants, but not in t
he control strains. In contrast, antifungals such as 5-flucytosine and hydr
oxypyridones inhibited growth of the kex2 mutants and the control strains t
o the same extent. In an in vitro model of oral candidosis, kex2 mutants sh
owed reduced tissue damage in the presence of itraconazole compared with th
e control infections. These data suggest that Kex2 is involved in the proce
ssing of proteins that are essential for cell surface integrity of C. glabr
ata.